Caption Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
VPM
VCM
QCM
Caption Management's NVCR Position: Q2 2024 in Review
Caption Management sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 2,493 shares — an estimated $39K sold.
Caption Management first reported a position in NVCR in Q3 2020 and held it in 6 quarters. The position peaked at $9.59M in Q4 2020. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.
- Caption Management reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
- Caption Management sold 2,493 NovoCure shares in Q2 2024, an estimated $39K.
- Caption Management first reported a position in NovoCure in Q3 2020 and held it in 6 quarters.
- Caption Management's NovoCure position peaked at $9.59M in Q4 2020.
- 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.
Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.